PsiThera, formerly Psivant Therapeutics, raises $47M for AI-designed oral drugs targeting immune conditions.
Browsing: Market & Financials
Market trends, financial performance, quarterly results, and investment insights from global pharma and biotech companies.
Hemophilia gene therapy faces market challenges despite innovation, with BioMarin, CSL, and Pfizer navigating barriers.
SciNeuro Pharmaceuticals funding of $53M aims to advance neurodegeneration drug development, supported by Arch Venture Partners.
FDA CDER leadership change sees Tracey Beth Høeg appointed as director, marking the fifth leadership shift in 2025.
Richard Pazdur retirement from FDA’s CDER marks a significant leadership change in 2025.
Novartis job cuts impact Swiss manufacturing, affecting hundreds of employees. Novo’s diabetes drug advances to Phase 3 trials. #Novartis #JobCuts #DiabetesDrug #PharmaSignal
Novartis job cuts affect hundreds in Swiss manufacturing, while Novo’s diabetes drug advances to Phase 3 trials.
Big Pharma CEO ratings reveal which leaders earn the highest employee approval, showcasing the impact of executive leadership on company culture.
Novartis job cuts affect hundreds in Swiss manufacturing, while Novo’s diabetes drug advances to Phase 3 trials.
Big Pharma CEO ratings reveal which leaders earn the highest employee approval, impacting company performance and satisfaction.